FHA
DPLO

Flagship Harbor Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Flagship Harbor Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-323
Closed -$6K – 2190
2018
Q3 		$6K Hold
323
– – ﹤0.01% 1663
2018
Q2 		$8K Buy
+323
New +$7.53K ﹤0.01% 1492

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Flagship Harbor Advisors's DPLO Position: Q4 2018 in Review

Flagship Harbor Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 323 shares — an estimated $6K sold.

Flagship Harbor Advisors first reported a position in DPLO in Q2 2018 and held it in 2 quarters. The position peaked at $8K in Q2 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Flagship Harbor Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Flagship Harbor Advisors sold 323 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $6K.
  • Flagship Harbor Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 2 quarters.
  • Flagship Harbor Advisors's DIPLOMAT PHARMACY, INC. position peaked at $8K in Q2 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Flagship Harbor Advisors's 13F filing for Q4 2018, filed 28 Jan 2019.